Immune Pharmaceuticals (IMNP) Receives FDA Guidance for Phase III Pivotal Trial POisitve interview with CMO & Principal Owner...positive feedback from FDA...look forward to 2017 for more updates! https://www.youtube.com/watch?v=N_NsxrwGmwg#action=share Investor 100